Nitroxoline: an option for the treatment of urinary tract infection with multi-resistant uropathogenic bacteria.

Link to article at PubMed

Related Articles

Nitroxoline: an option for the treatment of urinary tract infection with multi-resistant uropathogenic bacteria.

Infection. 2018 Nov 17;:

Authors: Hof H, Juretschke C

Abstract
The number of multi-resistant uropathogens is increasing. A multi-morbid patient developed a symptomatic urinary tract infection with two multi-resistant bacteria, namely Klebsiella pneumoniae and Proteus mirabilis. Nitroxoline was the only drug active against both uropathogens. Obviously, nitroxoline can be an option for the therapy of a urinary tract infection with multi-resistant uropathogens.

PMID: 30449013 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published. Required fields are marked *